Vol. 77 No. 2 (2025) | Reumatismo

Current Issue

Vol. 77 No. 2 (2025)

10 June 2025

View this Issue

Impact Factor 2025

Vol. 77 No. 2 (2025)

Published: 10 June 2025

Original Articles

Prevalence of musculoskeletal disorders in patients referred for suspected deep vein thrombosis: insights from a rheumatologist-led clinic

Nikoletta Svendsen, Philip Rask Lage-Hansen, Stavros Chrysidis

https://doi.org/10.4081/reumatismo.2025.1828

1369

PDF: 455
- PDF
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

https://doi.org/10.4081/reumatismo.2025.1694

2881

PDF: 559
- PDF
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with IgG4-related disease

Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

https://doi.org/10.4081/reumatismo.2025.1744

1876

PDF: 258

SUPPLEMENTARY MATERIAL: 102
- PDF
- SUPPLEMENTARY MATERIAL

Reviews

Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

https://doi.org/10.4081/reumatismo.2025.1754

2773

PDF: 528

SUPPLEMENTARY MATERIAL: 191
- PDF
- SUPPLEMENTARY MATERIAL
Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

https://doi.org/10.4081/reumatismo.2025.1718

2255

PDF: 386

SUPPLEMENTARY MATERIAL: 357
- PDF
- SUPPLEMENTARY MATERIAL

Case Reports

Tuberculosis infection in patients with dermatomyositis

Luis Carlos Palomino Romero, Alfredo Vargas Caselles, Natalia Soledad Rius, Enrique Soriano, Javier Rosa, Marina Scolnik

https://doi.org/10.4081/reumatismo.2025.1631

1423

PDF: 345
- PDF
Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors

Maria Iacovantuono, Chiara Bonini, Ernesto Di Biase, Vinicio Magliacani, Gian Domenico Sebastiani

https://doi.org/10.4081/reumatismo.2025.1756

1698

PDF: 343
- PDF
Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi

https://doi.org/10.4081/reumatismo.2025.1682

2723

PDF: 554
- PDF

Letters to the Editor

After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?

Ciro Manzo, Marco Isetta

https://doi.org/10.4081/reumatismo.2025.1823

1605

PDF: 339
- PDF

Viewpoints

To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody-associated vasculitis and giant cell arteritis

Alessandro Tomelleri, Christian Dejaco, Milena Bond

https://doi.org/10.4081/reumatismo.2025.1791

1822

PDF: 776
- PDF

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.